APPILI THERAPEUTICS INC-CL A (APLI.CA)
CA03783R1073 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.39M | 330K -76.26% | 827.41K 150.73% | -100.00% | ||
| EBITDA YoY % growth | -24.61M -57.25% | -7.9M 67.90% | -8.037M -1.73% | N/A | N/A | |
| EBIT YoY % growth | -24.62M -57.22% | -7.91M 67.87% | -8.05M -1.77% | -7.752M 3.70% | -8.058M -3.95% | |
| Operating Margin | -1,771.22% | -2,396.97% | -972.94% | N/A | N/A | |
| EPS YoY % growth | -0.40 -66.67% | -0.08 80.00% | N/A 49.00% | -0.04 | -0.04 |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 49.00% | -0.01 | % | |
| Q3 2024 Q2Q % growth | 0.00 100.00% | -0.01 | 0.01 | 100.00% |
| Q2 2024 Q2Q % growth | -0.01 | -0.02 | 0.01 | 50.98% |
| Q1 2024 Q2Q % growth | -0.01 66.67% | -0.02 | 0.01 | 50.98% |
| Q4 2023 Q2Q % growth | -0.02 60.00% | -0.02 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.02 60.00% | -0.02 | 0.00 | 1.96% |
| Q2 2023 Q2Q % growth | -0.01 94.44% | -0.02 | 0.01 | 50.98% |
| Q1 2023 Q2Q % growth | -0.03 75.00% | -0.03 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.05 37.50% | -0.10 | 0.05 | 50.98% |
| Q3 2022 Q2Q % growth | -0.05 28.57% | -0.07 | 0.02 | 29.97% |
| Q2 2022 Q2Q % growth | -0.18 -350.00% | -0.08 | -0.10 | -126.04% |
| Q1 2022 Q2Q % growth | -0.12 -140.00% | -0.06 | -0.06 | -96.08% |
| Q4 2021 Q2Q % growth | -0.08 -166.67% | -0.06 | -0.02 | -30.72% |
| Q3 2021 Q2Q % growth | -0.07 -75.00% | -0.04 | -0.03 | -71.57% |
| Q2 2021 Q2Q % growth | -0.04 | -0.06 | 0.02 | 30.80% |
| Q1 2021 Q2Q % growth | -0.05 | -0.05 | 0.00 | 1.96% |
| Q4 2020 Q2Q % growth | -0.03 | -0.03 | 0.00 | 1.96% |
| Q3 2020 Q2Q % growth | -0.04 | -0.04 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.69K -98.62% | % | ||
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | 11.7K -96.57% | 11.7K | % | |
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 306K | -306K | -100.00% |
| Q3 2020 Q2Q % growth | 200K | 102K | 98K | 96.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |